Acadian Asset Management
TMDX icon

Acadian Asset Management’s Transmedics TMDX Stock Holding History

Acadian Asset Management’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$243K Sell
2,451
-6,667
-73% -$870K ﹤0.01% 1534
2025
Q4 		$1.11M Buy
9,118
+8,647
+1,836% +$1.09M ﹤0.01% 1096
2025
Q3 		$52K Buy
+471
New +$55.1K ﹤0.01% 1637
2024
Q4 		– Sell
-2,248
Closed -$352K – 2159
2024
Q3 		$352K Buy
+2,248
New +$346K ﹤0.01% 1175
2023
Q3 		– Sell
-7,871
Closed -$661K – 1843
2023
Q2 		$661K Buy
7,871
+3,994
+103% +$306K ﹤0.01% 983
2023
Q1 		$293K Buy
+3,877
New +$268K ﹤0.01% 1179

Other funds holding TMDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Acadian Asset Management's TMDX Position: Q1 2026 in Review

Acadian Asset Management reduced its Transmedics (TMDX) stake by 73% in Q1 2026, selling an estimated $870K and leaving 2,451 shares worth $243K. The position accounts for ﹤0.01% of the portfolio, ranked #1534.

Acadian Asset Management first reported a position in TMDX in Q1 2023 and has held it in 6 quarters since. The position peaked at $1.11M in Q4 2025. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

  • Acadian Asset Management held 2,451 shares of Transmedics worth $243K as of Q1 2026.
  • Acadian Asset Management sold 6,667 Transmedics shares in Q1 2026, an estimated $870K.
  • Transmedics made up ﹤0.01% of Acadian Asset Management's portfolio in Q1 2026, its #1534 holding.
  • Acadian Asset Management first reported a position in Transmedics in Q1 2023 and has held it in 6 quarters since.
  • Acadian Asset Management's Transmedics position peaked at $1.11M in Q4 2025.
  • 414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Acadian Asset Management's 13F filing for Q1 2026, filed 13 May 2026.